首页|期刊导航|中华医学杂志（英文版）|Fc fragment of immunoglobulin G receptor Ⅱa(FCGR2A)as a new potential prognostic biomarker of esophageal squamous cell carcinoma

Fc fragment of immunoglobulin G receptor Ⅱa(FCGR2A)as a new potential prognostic biomarker of esophageal squamous cell carcinoma

Sifen Lu Nan Li Zhiqiang Peng Zuhong Lu Xingyue Tu Wengeng Zhang Yulin Kang

中华医学杂志（英文版）2022，Vol.135Issue(4)：482-484,3.

中华医学杂志（英文版）2022，Vol.135Issue(4)：482-484,3.DOI:10.1097/CM9.0000000000001776

Fc fragment of immunoglobulin G receptor Ⅱa(FCGR2A)as a new potential prognostic biomarker of esophageal squamous cell carcinoma

Sifen Lu ¹Nan Li ²Zhiqiang Peng ³Zuhong Lu ⁴Xingyue Tu ⁵Wengeng Zhang ¹Yulin Kang⁵

作者信息

1. Precision Medicine Key Laboratory of Sichuan Province and Precision Medicine Center,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,China
2. Department of Information Center and National Clinical Research Center for Geriatrics,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,China
3. State Key Laboratory of Proteomics,National Center for Protein Sciences(Beijing),Beijing Institute of Lifeomics,Beijing 100850,China
4. State Key Lab of Bioelectronics,National Demonstration Center for Experimental Biomedical Engineering Education,School of Biological Science and Medical Engineering,Southeast University,Nanjing,Jiangsu 210096,China
5. Institute of Environmental Information,Chinese Research Academy of Environmental Sciences,Beijing 100012,China
折叠

摘要

引用本文复制引用

Sifen Lu,Nan Li,Zhiqiang Peng,Zuhong Lu,Xingyue Tu,Wengeng Zhang,Yulin Kang..Fc fragment of immunoglobulin G receptor Ⅱa(FCGR2A)as a new potential prognostic biomarker of esophageal squamous cell carcinoma[J].中华医学杂志（英文版）,2022,135(4):482-484,3.

基金项目

This study was supported by the grants from National Key Development Plan for Precision Medicine Research,China(No.2017YFC0910004),Sichuan Science and Technology Program,China(No.2017HH0044),and Chengdu Science and Technology Program,China(No.2017-CY02-00017-GX). （No.2017YFC0910004）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINESCI

ISSN：0366-6999

访问量0

下载量0

段落导航